x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

health & fitness medicine

All Episodes

10:42

The Psych Guide to Ketamine and Esketamine

Psychopharmacology and Psychiatry Updates ·

2019/09/19

In this podcast episode we learn the core concepts surrounding ketamine and esketamine; a very hot topic in psychiatry today. We have Dr. Sam Wilkinson and Dr. Joseph Goldberg joining us. Download a PDF of this interview here Learn more about our memberships here

en

14:58

Your Psych Guide To Pharmacogenetic Testing

Psychopharmacology and Psychiatry Updates ·

2019/08/28

In this podcast episode, we dig further into the practical use of pharmacogenetic testing in psychiatric practice. We address its limitations and the resources you can use to guide your decision making. Download a PDF of this interview here Learn more about our memberships here

en

16:08

Do You Order Pharmacogenetic Testing For Your Patients?

Psychopharmacology and Psychiatry Updates ·

2019/08/14

In this podcast episode, we question whether pharmacogenetic testing is valuable in psychiatry practice. Joined by Dr. Simon Kung and Dr. Michael Thase, we find answers to this question! Download a PDF of this interview here Learn more about our memberships here

en

15:55

Podcast: Give Me Some Skin-Transdermal Patches in...

Psychopharmacology and Psychiatry Updates ·

2019/07/31

In this podcast interview with Dr. Leslie Citrome, we venture into the topic of transdermal delivery of psychotropics. We explore the challenge of creating patches and also peek into the latest antipsychotics in clinical trials for transdermal delivery. Download a PDF of this interview here Learn more about our memberships here

en

19:39

Podcast: Your Guide to Synthetic Opioids and Bath Salts

Psychopharmacology and Psychiatry Updates ·

2019/07/17

This podcast episode covers the basics of diagnosing and managing novel synthetic opioids and synthetic cathinones. Download a PDF of this interview here Learn more about our memberships here

en

15:56

Designer Drugs: Can You Handle Spice?

Psychopharmacology and Psychiatry Updates ·

2019/07/03

The use of designer drugs (novel psychoactive compounds) is rapidly-growing and dangerous, this podcast episode gives you exactly what you need to know to identify and manage these cases. Download a PDF of this interview here Learn more about our memberships here

en

18:27

What You Need To Know About Psychedelics

Psychopharmacology and Psychiatry Updates ·

2019/06/19

Psychedelics mimic serotonin and work as 5-HT2A agonists in the brain. They stimulate receptors largely localized in the association cortex. MDMA can help patients with PTSD by damping down emotional responses and so allowing processing of traumatic memories. In patients with treatment-resistant depression, psilocybin increased amygdala activity, which is the opposite effect of SSRIs. Download a PDF of this interview here Learn more about our memberships here

en

23:34

The Magic of the Serotonin Receptors

Psychopharmacology and Psychiatry Updates ·

2019/05/31

Here is a summary of this episode: The 5-HT1A receptor is responsible for passive coping with stress, anxiolytic, anti-anxiety and anti-aggression effects. The 5-HT2A receptor is responsible for more active coping, cognitive flexibility, and creative thinking. The 5-HT2A receptor is the most abundant serotonin receptor in the cortex and is particularly found in the prefrontal, cingulate, and posterior cingulate cortex. Download a PDF of this interview here Learn more about our memberships

en

17:51

Generalized Anxiety Disorder: What if You Can’t Use...

Psychopharmacology and Psychiatry Updates ·

2019/05/16

Today’s question is: What if You Can’t Use An SSRI in GAD? Here is a summary of this episode: The first-line alternatives to SSRIs in GAD are SNRIs, buspirone, hydroxyzine, pregabalin, and bupropion. Benzodiazepines are not recommended first-line agents for GAD due to their prominent side effect profile. Antipsychotics are not recommended as augmenting agents in GAD due to their high risk of metabolic side effects, negative effects on insulin resistance. Download a PDF of this interview here

en

18:06

Approaching A Case of Generalized Anxiety Disorder:...

Psychopharmacology and Psychiatry Updates ·

2019/05/03

Today’s question is: How to approach a case of generalized anxiety disorder? Here is a summary of this episode: GAD is a disorder of chronic, excessive worrying. Ensure you have the correct diagnosis according to DSM-5. For patients with bipolar depression, do not use an antidepressant. Instead, you may use hydroxyzine, pregabalin, or benzodiazepines. The first-line treatments are SSRIs. Escitalopram and paroxetine are FDA-approved. Sertraline is also recommended as a possible first-line agent.

en

16:12

How Helpful are Antipsychotic Plasma Levels?

Psychopharmacology and Psychiatry Updates ·

2019/04/17

Today’s question is: how helpful are antipsychotic plasma levels? Here is a summary of this episode: Plasma level is the best proxy for antipsychotic CNS action. Getting levels can detect nonadherence, the point of futility and kinetic issues. Plasma levels can tell you whether you have room for further dose increases. We can measure levels at the start of antipsychotic treatment, in nonresponders and in patients with a change in clinical status. It is also an essential part of clozapine therapy

en

15:17

Should You Prescribe Natural Medications? Part 2

Psychopharmacology and Psychiatry Updates ·

2019/04/08

Today’s question is: Here is a summary of this episode: Melatonin is a relatively safe sleep aid with few side effects. It may inhibit fertility, sex drive, as well as having immunosuppressive activity. Valerian officinalis works through GABA-ergic compounds and could be just as efficacious as benzodiazepines as a hypnotic. It should be taken at least 2 hours before bed. Ginkgo biloba is a cognition-enhancing drug that may prevent cognitive decline and treat antidepressant-induced sexual

en

15:17

How to Prescribe Natural Medications? Part 1

Psychopharmacology and Psychiatry Updates ·

2019/03/21

Today’s question is: Should you prescribe natural medications? Here is a summary of this episode: St. John’s wort and Rhodiola rosea have been found to cause serotonin syndrome when combined with SSRIs. St. John’s wort, SAM-e and omega 3 fatty acids may cause switching to hypomania and mania in patients with bipolar disorder. Correcting the ratio of omega-6 to omega-3 seems to correlate with the degree of improvement in depression. The omega-3s are found primarily in fish oil and in certain types

en

13:53

How to Manage Adverse Effects of Clozapine – Part 2

Psychopharmacology and Psychiatry Updates ·

2019/03/08

Today’s question is: How to manage the non-hematological adverse effects of clozapine? Here is a summary of this episode: Clozapine can commonly cause a benign fever. If a patient is feverish, do a workup to exclude infections, myocarditis, NMS and inflammatory conditions. For orthostatic hypotension, slowly titrate, encourage fluid intake and avoid other alpha 1 blockers and benzodiazepines. You can consider using 9-fludrocortisone for volume expansion. In cases of tachycardia, manage orthostasis

en

16:44

How to Manage Adverse Effects of Clozapine – Part 1

Psychopharmacology and Psychiatry Updates ·

2019/02/21

Today’s question is: How to manage the non-hematological adverse effects of clozapine? Here is a summary of this episode: For sialorrhea start with local agents like sublingual atropine drops or mouth ipratropium spray. If that fails, systemic agents like glycopyrrolate or terazosin can be used. For constipation, bulk agents can make constipation worse and should be avoided. After docusate, the next agent to add is PEG 3350 and then a stimulant and then lastly, if needed, lubiprostone. For

en

13:27

Do SSRIs Increase Bleeding Risk?

Psychopharmacology and Psychiatry Updates ·

2019/02/06

Today’s question is: Do SSRIs increase the risk of bleeding? Here is a summary of this episode: Prescribe SSRIs with caution in patients with a defect in platelet number or function and those with H.pylori infection. Concomitant SSRI and NSAID use is only of concern in patients taking daily and/or high doses. Avoid prescribing fluvoxamine with warfarin. There are no other warnings regarding the use of SSRIs and anticoagulants. It is generally not recommended to stop an SSRI before delivery and the

en

11:48

Your Guide to Treating PTSD Comorbidities

Psychopharmacology and Psychiatry Updates ·

2019/01/25

Today’s question is: How to manage the comorbidities of PTSD? Here is a summary of this episode: Screen for substance use and avoid prescription drugs like benzodiazepines. Desipramine and topiramate might help with comorbid alcohol use disorder. In PTSD-related psychosis, try an SSRI first. If that doesn’t help, add a second-generation antipsychotic like risperidone. Prescribe paroxetine with caution in women of childbearing potential. Download a PDF of this interview here Learn more about our

en

20:04

How to Treat PTSD-Related Sleep Disturbances?

Psychopharmacology and Psychiatry Updates ·

2019/01/09

Today’s question is: How to treat sleep disturbances in patients with PTSD? Here is a summary of this episode: Prazosin is recommended as a first-line agent in sleep disturbances in PTSD with an average dose for men at 16 mg and for women, 7 mg titrated over 5 weeks. Trazodone can be used in patients with initial-sleep insomnia with PTSD at a starting dose of 50 mg. Avoid benzodiazepines due to its abuse potential. Also, its cognitive side effects may negatively affect psychotherapy

en

10:39

Prescribing Psychotropics in the Medically Ill

Psychopharmacology and Psychiatry Updates ·

2018/12/28

Here is a summary of this episode: In patients with liver impairment, it is better to use drugs that are metabolized by phase II enzymes or drugs that are not metabolized by the liver at all. Patients with severe renal impairment may also have liver impairment. Use ⅔ of the recommended dose. Benzodiazepines and Z-drugs are contraindicated in CO2 retainers and those with severe sleep apnea. Opiates are better than benzodiazepines in patients with terminal breathlessness. Download a PDF of this

en

16:47

Psychotropics and Gastrointestinal Conditions:...

Psychopharmacology and Psychiatry Updates ·

2018/12/14

Here is a summary of this episode: Always ask about over-the-counter drugs like antacids, antiemetics, and spasmolytics as they may interfere with drug absorption. In patients who have undergone gastric bypass, use immediate release formulations, or give liquid form of drugs. There is evidence to suggest that IBS-constipation responds better to SSRIs and IBS-diarrhea to TCAs. The risk of GIT bleeding with SSRIs is 1.5 to 2 times greater. Patients with a defect in platelet number or function and

en

427 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown